KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 117 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $546,000 | -9.6% | 160,600 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $604,000 | -8.1% | 160,600 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $657,000 | -0.6% | 160,600 | +13.0% | 0.00% | 0.0% |
Q4 2017 | $661,000 | -28.7% | 142,100 | +8.9% | 0.00% | 0.0% |
Q3 2017 | $927,000 | -1.8% | 130,500 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $944,000 | +17.4% | 130,500 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $804,000 | +5.1% | 130,500 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $765,000 | -0.9% | 130,500 | -10.2% | 0.00% | 0.0% |
Q3 2016 | $772,000 | -19.8% | 145,400 | 0.0% | 0.00% | -50.0% |
Q2 2016 | $963,000 | +21.1% | 145,400 | -17.4% | 0.00% | +100.0% |
Q1 2016 | $795,000 | +9.2% | 176,100 | +22.1% | 0.00% | -50.0% |
Q4 2015 | $728,000 | +43.3% | 144,200 | 0.0% | 0.00% | +100.0% |
Q3 2015 | $508,000 | -59.9% | 144,200 | +13.6% | 0.00% | -66.7% |
Q2 2015 | $1,266,000 | -9.9% | 126,900 | +14.9% | 0.00% | -25.0% |
Q1 2015 | $1,405,000 | +0.1% | 110,400 | +11.3% | 0.00% | -20.0% |
Q4 2014 | $1,404,000 | +5.2% | 99,200 | +2.3% | 0.01% | 0.0% |
Q3 2014 | $1,334,000 | -10.6% | 97,000 | 0.0% | 0.01% | -16.7% |
Q2 2014 | $1,492,000 | -9.7% | 97,000 | 0.0% | 0.01% | 0.0% |
Q1 2014 | $1,653,000 | +82.7% | 97,000 | +38.8% | 0.01% | +50.0% |
Q4 2013 | $905,000 | +28.2% | 69,900 | 0.0% | 0.00% | +33.3% |
Q3 2013 | $706,000 | +28.1% | 69,900 | -5.3% | 0.00% | +50.0% |
Q2 2013 | $551,000 | – | 73,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |